VHL gene inactivation is a hallmark of von Hippel–Lindau syndrome, a hereditary disorder predisposing patients to ccRCC and other tumors, underscoring its central role in disease pathogenesis. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.